Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677220 · ClinicalTrials.gov registry record · NA
Implantation With the Nucleus CI532 Cochlear Implant in Adults
A NA study, sponsored by Cochlear.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02677220: Clinical Trial NA study, sponsored by Cochlear.
NCT02677220 is a NA study that was terminated before completion, run by Cochlear. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02677220, a NA study, was terminated before completion, sponsored by Cochlear.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant. The Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.
Primary Outcome
The AzBio Sentence test was recorded at 3 months prior to subject withdraw. Not collected at endpoint. AzBio Tests consists of 15 lists of 20 sentences each. AzBio sentences are spoken by different talkers in a conversational style with limited contextual cues that the listener can use to predict or 'fill in' unintelligible words. Each list includes 5 sentences from 4 different male and female speakers. Each word in the sentence counts toward the overall score and the resulting score is presente
Interventions
- DEVICE CI532 cochlear implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-05-11 |
| Est. Completion | 2017-08-23 |
| Phase | NA |
Why NCT02677220 stopped before completion
NCT02677220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which CI532 cochlear implant is the first listed.
NCT02677220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02677220 about?
NCT02677220 is a clinical study titled "Implantation With the Nucleus CI532 Cochlear Implant in Adults". The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant. The Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.
What is the current status of trial NCT02677220?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-05-11. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02677220?
The interventions under investigation include: CI532 cochlear implant (DEVICE).
Who is sponsoring clinical trial NCT02677220?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02677220's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI